1. Home
  2. YRD vs VRCA Comparison

YRD vs VRCA Comparison

Compare YRD & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

HOLD

Current Price

$1.00

Market Cap

88.4M

Sector

Finance

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$4.62

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YRD
VRCA
Founded
2012
2013
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.4M
88.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
YRD
VRCA
Price
$1.00
$4.62
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
42.1K
83.3K
Earning Date
06-11-2026
05-11-2026
Dividend Yield
23.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
$1.86
N/A
Revenue Growth
N/A
370.22
52 Week Low
$0.82
$3.28
52 Week High
$6.79
$9.82

Technical Indicators

Market Signals
Indicator
YRD
VRCA
Relative Strength Index (RSI) N/A 42.61
Support Level N/A $4.65
Resistance Level N/A $5.94
Average True Range (ATR) 0.00 0.28
MACD 0.00 -0.03
Stochastic Oscillator 0.00 21.95

Price Performance

Historical Comparison
YRD
VRCA

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: